QQ客服 官方微博 反馈留言

	Recombinant EGFR/MMP-2 bi-targeted fusion protein markedly binding to non-small-cell lung carcinoma and exerting potent therapeutic efficacy
	Xu, Jian; Du, Yue; Liu, Xiu-Jun; Zhu, Bing-Yan; Zhang, Sheng-Hua; Li, Liang; Li, Yi; Wang, Xiao-Fei; Shan, Chuan-Kun; Wang, Rui-Qi
	2017
卷号	126期号:,SI页码:66-76
关键词	Fusion protein Delivery carrier EGFR/MMP-2 bi-targeted Enediyne Therapeutic efficacy
ISSN号	1043-6618
DOI	10.1016/j.phrs.2017.04.001
URL标识	查看原文
收录类别	SCIE ; PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6367830
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Xu, Jian,Du, Yue,Liu, Xiu-Jun,et al. Recombinant EGFR/MMP-2 bi-targeted fusion protein markedly binding to non-small-cell lung carcinoma and exerting potent therapeutic efficacy[J],2017,126(,SI):66-76.
APA	Xu, Jian.,Du, Yue.,Liu, Xiu-Jun.,Zhu, Bing-Yan.,Zhang, Sheng-Hua.,...&Zhen, Yong-Su.(2017).Recombinant EGFR/MMP-2 bi-targeted fusion protein markedly binding to non-small-cell lung carcinoma and exerting potent therapeutic efficacy.,126(,SI),66-76.
MLA	Xu, Jian,et al."Recombinant EGFR/MMP-2 bi-targeted fusion protein markedly binding to non-small-cell lung carcinoma and exerting potent therapeutic efficacy".126.,SI(2017):66-76.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。